DrugCombination product
Petrelintide clinical trials
Also written ZP8396 and RO7895515.
- studies test it
- 11
- open now
- 5
- in phase 3
- 3
- first study started
- 2021
Keep track of what changes. Save the petrelintide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
11 studies that test it; most in 2026 (5)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 3
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses petrelintide is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular DiseaseRecruitingPhase 3Hoffmann-La RocheNCT07843472Written as Petrelintide
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 DiabetesRecruitingPhase 3Hoffmann-La RocheNCT07843485Written as Petrelintide
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or ObesityRecruitingPhase 3Hoffmann-La RocheNCT07843498Written as Petrelintide
- A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or OverweightNot yet recruitingPhase 2Hoffmann-La RocheNCT07589686Written as Petrelintide
- Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic FunctionRecruitingPhase 1Zealand PharmaNCT07682818Written as Petrelintide
- Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)CompletedPhase 2Zealand PharmaNCT06926842Written as Petrelintide
- Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product ConcentrationsCompletedPhase 1Zealand PharmaNCT07338214Written as Petrelintide
- Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbiditiesCompletedPhase 2Zealand PharmaNCT06662539Written as Petrelintide
- Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal FunctionCompletedPhase 1Zealand PharmaNCT07076030Written as Petrelintide
- A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy ParticipantsCompletedPhase 1Zealand PharmaNCT05613387Written as ZP8396
- A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial ParticipantsCompletedPhase 1Zealand PharmaNCT05096598Written as ZP8396
Codes
What other systems call petrelintide · ClinicalTrials.gg INT016298
- UNII (FDA) D78KBY7BRUPETRELINTIDEOne source FDA
- NCI Thesaurus C203201PetrelintideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | D78KBY7BRU | PETRELINTIDE | One source FDA |
| NCI Thesaurus | C203201 | Petrelintide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.